Innovation News Pharma & Biotechnology

AstraZeneca leaning towards two dose strategy for COVID-19 vaccine

AstraZeneca’s is looking to test two high doses of its experimental vaccine against the new coronavirus in later stage trials rather than focus on approval for single or lower doses of the vaccine, its biopharma chief said on Monday.

“Right now, the safe thing to do is go with two doses, and then we’ll start exploring single doses or lower doses,” Mene Pangalos, executive vice-president for BioPharmaceuticals R&D, told reporters.

Read More

Meeta Ramnani
Meeta Ramnani
Meeta develops credible content about various markets based on deep research, opinions from experts and inputs from industry leaders. As the managing editor at Smart Industry News, she assures that every piece of news and article adds to the knowledge of decision makers. An avid bike rider, Meeta, is a postgraduate from Indian Institute of Journalism and New Media (IIJNM) Bangalore, where her specialization was Business Journalism. She carries experience from mainstream print media including The Times Group and Sakal Media Group.